Estonia

BMI View: The key drawback to investment in Estonia's drug market is its small size and moderate-to-weak outlook for growth. However, compared to its Baltic peers, Estonia's drug market... 2011-03-25

BMI View: The economies of Lithuania, Estonia and Latvia were among the worst hit in Europe during the global economic crisis of 2007-2010 and the region's drug markets have not been... 2011-03-08

BMI View: The availability of a highly educated scientific workforce is of vital importance to drugmakers seeking to either outsource or transfer manufacturing and research and development... 2011-02-24

BMI View: Despite Krka reporting relatively strong financial results in first nine months of 2010, BMI believes frequent temporary bans and continuous allegations of patent infringements... 2011-01-20

BMI View: The attractiveness of Central and Eastern Europe (CEE) to multinational pharmaceutical companies has increased. The region scored 51.6 out of 100 in BMI's Pharmaceutical &... 2011-01-13

BMI View: The economies of Lithuania, Estonia and Latvia were among the worst hit in Europe during the global economic crisis of 2007-2010 and the region's drug markets have not been... 2010-12-16

BMI View: Despite stronger than expected pharmaceutical sales during the first nine months of 2010, BMI's projection that Estonia will post only marginal growth in 2010 has been confirmed.... 2010-11-29